Spectrum News: Syphilis cases are increasing in pregnant women
UC expert says early detection is critical
According to the Centers for Disease Control and Prevention, the rate of syphilis cases among pregnant women in Ohio nearly doubled between 2016 and 2022. Syphilis is a treatable bacterial infection that is spread through intimate contact.
Without treatment, the mother's health can be affected, and the child may develop birth defects or be stillborn. That is why medical professionals say it is important to get prenatal care as early as possible.
Spectrum News produced a story interviewing Meredith Pensak, MD of the Department of Obstetrics and Gynecology and Carl Fichtenbaum, MD of the Division of Infectious Diseases, both in the UC College of Medicine.
“We know that catching syphilis early in pregnancy and treating it can significantly decrease the risk of stillbirth,” said Pensak. “It can decrease the risk of preterm birth, low birth weight and neonatal demise and death.”
Pensak, who is a member of the Hamilton County Congenital Syphilis Review Board, has been studying it for years and knows just how much of an impact it has had on her patients.
"We're seeing this increased rate of congenital syphilis of babies being born with syphilis and the issues that come with that," Pensak told Spectrum News.
Fichtenbaum says the issues become even more serious if a pregnant woman passes it on to her child in the womb.
"If it happens when the child is developing in the first or second trimester of pregnancy, there can be birth defects associated with it that are long-lasting and can not be reversed," said Fichtenbaum.
That's why Pensak said it's important to detect it early on during pregnancy.
"We know that a lack of prenatal care increases your risk of having congenital syphilis and these complications," Pensak said who added insurance issues for some is contributing to the problem.
"We see patients with unstable housing might not have access and we see that, in general, there has also been reduced public awareness," she said. "We know that catching syphilis early in pregnancy and treating it can significantly reduce the risk of still birth, it can decrease the risk of pre-term birth, it can decrease the risk of low birth rate, and it can decrease the risk of neonatal demise and death.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Local 12: Music creation's impact on the brain after cancer
August 4, 2021
UC researchers launched a new study looking treating a common brain problem that results after therapy for cancer.
WLWT: COVID-19 vaccine distribution in Ohio
January 11, 2021
COVID-19 vaccine providers across Ohio will soon get better guidance about the next steps for getting shots into arms. Brett Kissela, MD, spoke to WLWT-TV, Channel 5 and said the benefits of the vaccine outweigh any potential side effects.
What's Happening in Health: RNA treatment for brain cancer
May 18, 2021
UC's Daniel Pomeranz Krummel, PhD, discusses new brain cancer research with Liz Bonis on Local 12's What's Happening in Health program.
'I'm a believer': UC dean for research takes next step in COVID-19 trial
January 8, 2021
Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health, learned he received the placebo in the Moderna vaccine clinical trial. He then received the real vaccine to show that he believes in the science.
MedPage Today: Preop chemotherapy misses mark in pancreatic cancer
January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
COVID-19 Conversations Podcast: Participation in vaccine trial
December 17, 2020
UC's Brett Kissela, MD, discusses participating in the Moderna vaccine trial on an African Alliance podcast.
WVXU: Does your spinal fluid show if you have a tumor?
November 9, 2020
University of Cincinnati researchers are starting a clinical trial to determine if they can detect brain cancer in spinal fluid.
US News & World Report: Immunotherapy and cancer, COVID-19
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
Drugs.com: Effect of cancer treatment on COVID-19 mortality
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
WVXU: Certain cancer treatments & COVID-19 could lead to death
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.